ArticleCell death discovery2023

Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer.

Xianzhe Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.